Fulcrum Therapeutics, Inc. · NASDAQ:FULC

Nantahala Capital Management, LLC reported a 8.22% stake in Fulcrum Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 14, 2026

Nantahala Capital Management, LLC reported a 8.22% stake in Fulcrum Therapeutics, Inc., 5,475,040 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).

Stake
8.22%
Shares
5,475,040
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC8.22%5,475,040
Wilmot B. Harkey8.22%5,475,040
Daniel Mack8.22%5,475,040

Source

View original at SEC

Related